New Skin in the Game™

Introducing NeoMatriX®

NeoMatriX® Wound Matrix is fabricated from the dermal extracellular matrix of axolotl.  NeoMatriX® is provided in the form of sheets of various sizes for placement on wound beds to help manage the wound environment.

INTENDED USE/INDICATION FOR USE

  • Partial and full-thickness wounds

  • Pressure ulcers

  • Venous ulcers

  • Diabetic foot ulcers

  • Chronic vascular ulcers

  • Tunneled/undermined wounds

  • Surgical wounds (donor sites/grafts, post Moh’s surgery, post-laser surgery,

    podiatric and dehiscence)

  • Trauma wounds (abrasions, lacerations, partial thickness burns and skin tears)

  • Draining wounds

Rx ONLY Refer to IFU supplied with each device for indications, contraindication, and precautions

Product Advantages

  • Easy to use, off the shelf

  • Room temperature storage

  • Terminally sterilized using gamma irradiation for additional level of safety

  • Supplied in a double peel-pouch package for convenient use

  • The ECM matrix conforms to the wound bed upon application and can be hydrated with sterile saline as needed

Product Evidence

Wanna stay Updated?

Follow us on LinkedIn and Twitter

Product Specifications:

NeoMatriX® Wound Matrix (A2021)

Axolotl derived sterile acellular dermal membrane gamma irradiated at 20-24kGy to a sterility assurance level of 10-6

Product Number Product Description SQ CM
FDSD0203 2x3 cm ellipse 4.50
FDSD0103 1x3 cm strip 3.00
FDSD0102 1x2 cm ellipse 1.40
FDSD0020 20 mm disk 3.00
FDSD0015 15 mm disk 1.70
FDSD0010 10.5 mm disk 0.80
FDSD0008 8 mm disk 0.45
FDSD0810 10 pk of 8 mm disks (special order only) 4.50

Product is stored at room temperature (15-30 Deg C) in dual pouch system consisting of:

  • Outer Pouch - 4”x7” Tyvek (1073B) / Clear (TPF-0501A)

  • Inner Pouch - 2.75” x 4.5” Clear (TPS-4051) / Foil (TPF-0599B)

Our Patents

NextGen Biologics, Inc., is the owner of the below listed United States and Foreign Patents, Patent Applications, and Registered Trademarks:

Patent # Title Description Country
US 10,617.790' Decellularized Biomaterial from Non-mammalian Tissue Issued Patent U.S.
US 11,660,376 Decellularized Biomaterial from Non-mammalian Tissue Issued Patent U.S.
US 12,311,079 Decellularized Biomaterial from Non-mammalian Tissue Issued Patent U.S.
JP 6606429 Decellularized Biomaterial from Non-mammalian Tissue Issued Patent Japan
EP 2943209
(FR, DE, & GB)		 Decellularized Biomaterial from Non-mammalian Tissue Issued Patent EU (GB, DE, FR)
IL 239828 Decellularized Biomaterial from Non-mammalian Tissue Issued Patent Israel
CN 105246495 Decellularized Biomaterial from Non-mammalian Tissue Issued Patent China
KR 10-2284982 Decellularized Biomaterial from Non-mammalian Tissue Issued Patent Korea
CA 2897662 Biomaterial from Non-mammalian Tissue Issued Patent Canada
Pending
USSN 16/801,956 Biomaterial from Non-mammalian Tissue Pending US Application U.S.
Expired
WO2014110269 Decellularized Biomaterial from Non-mammalian Tissue Expired PCT International
US61/750,555 Decellularized Biomaterial from Non-mammalian Tissue Expired provisional Expired provisional application
Trademarks
5449020 NEOMATRIX® Standard Character Mark U.S.

1 Pursuant to 35 USC 287, public and free access to this information constitutes public notice of the existence of US Patent No. 10,617,790.